#Urinalysis

Mekorot invests in Olive Diagnostics to allow early detection of chemicals in the Kinneret and water reservoirs

Olive Diagnostics extends seed round with additional $1.5 million

Olive Diagnostics received the CE Marking in Europe for its AI-powered optical urine analysis device Olive KG. Following the EU approval, Olive received first orders for the product from two European organizations.

AI-based urine analysis displays real-time health on Apple Watch

Olive WatchOS app connects to its AI-based real-time urine analysis device that mounts to any toilet. The IoT device can detect biomarkers when a person urinates normally in the toilet and alerts for the risks of conditions including dehydration and Urine Tract Infections. Clinical trials have already validated the accuracy measuring concentrations of molecules Albumin, RBC, Nitrite, pH, specific gravity and volume that are relevant to heart failure, kidney stones, renal failure, and other conditions.

Olive Diagnostics’ 100% passive urine analysis device accurately detects biomarkers for kidney stones, UTI and heart failure

Recently completed clinical trial provides third party validation of the accuracy of Olive's continuous monitoring technology over traditional urine sticks. The 100% passive device, which mounts to any toilet, can provide early detection of diseases, and helps deliver improved quality of life and reduce healthcare costs.